25.11.2014 Views

tumor cell biology program - Sylvester Comprehensive Cancer Center

tumor cell biology program - Sylvester Comprehensive Cancer Center

tumor cell biology program - Sylvester Comprehensive Cancer Center

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Jiang, Z, Podack, ER and Levy, RB.<br />

Donor T <strong>cell</strong>s which cannot mediate<br />

perforin dependent and FasL-dependent<br />

cytotoxicity can effect graft versus host<br />

reactivity following allogeneic bone<br />

marrow transplantation. Periodicum<br />

Biologorum 100:477, 1999.<br />

Petito, CK, Kerza-Kwiatecki, AP,<br />

Gendelman, HE, McCarthy, M, Nath,<br />

A, Podack, ER, Shapshak, P and Wiley,<br />

CA. Neuronal injury in HIV infection.<br />

Journal of Neurovirology 5:327, 1999.<br />

Prpic, L, Strbo, N, Sotosek, V,<br />

Gruber, F, Podack, ER and Rukavina, D.<br />

Assessment of perforin expression in peripheral<br />

blood lymphocytes in psoriatic<br />

patients during exacerbation of disease.<br />

Acta Dermato-Venereologica. Supplementum<br />

211:14, 2000.<br />

Muta, H, Boise, LH, Fang, L and<br />

Podack, ER. CD30 signals integrate expression<br />

of cytotoxic effector molecules,<br />

lymphocyte trafficking signals, and signals<br />

for proliferation and apoptosis. Journal<br />

of Immunology 165:5105, 2000.<br />

Rukavina, D and Podack, ER.<br />

Abundant perforin expression at the<br />

maternal-fetal interface: guarding the<br />

semiallogeneic transplant. Immunology<br />

Today 21:160, 2000.<br />

Jiang, Z, Podack, ER, Levy, RB.<br />

Major histocompatibility complex-mismatched<br />

allogeneic bone marrow transplantation<br />

using perforin and/or Fasligand<br />

double-defective CD4(+) donor<br />

T <strong>cell</strong>s: involvement of cytotoxic function<br />

by donor lymphocytes prior to graftversus-host<br />

disease pathogenesis. Blood<br />

98:390, 2001.<br />

Ohshima, K, Kawasaki, C, Muta, H,<br />

Muta, K, Deyev, V, Haraoka, S,<br />

Suzumiya, J, Podack, ER and Kikuchi,<br />

M. CD10 and Bcl10 expression in diffuse<br />

large B-<strong>cell</strong> lymphoma: CD10 is a<br />

marker of improved prognosis. Histopathology<br />

39:156, 2001.<br />

Ohshima, K, Muta, H, Kawasaki, C,<br />

Muta, K, Deyev, V, Kanda, M, Kumano,<br />

Y, Podack, ER and Kikuchi, M. Bcl10<br />

expression, rearrangement and mutation<br />

in MALT lymphoma: Correlation with<br />

expression of nuclear factor-kappa B.<br />

International Journal of Oncology<br />

19:283, 2001.<br />

Hnatyszyn, H, Podack, ER, Young,<br />

AK, Seivright, R, Spruill, G and Kraus,<br />

G. The use of real-time PCR and<br />

fluorogenic probes for rapid and accurate<br />

genotyping of newborn mice. Molecular<br />

Cell Probes 15:169, 2001.<br />

HIGHLIGHTS/DISCOVERIES<br />

• Heatshock fusion vaccines generate<br />

CD8 CTL without CD4 help: progress<br />

towards novel and efficient <strong>tumor</strong> specific<br />

vaccines.<br />

• CD30 is identified as a major negative<br />

regulator of cytotoxic lymphocytes:<br />

blocking CD30 signals in vivo will dramatically<br />

enhance anti-<strong>tumor</strong> immune<br />

responses.<br />

• Generation of the first murine gene<br />

knock in Florida: CD30-Ligand<br />

knock-out in mice will serve as a valuable<br />

model for <strong>tumor</strong> and autoimmunity<br />

studies.<br />

• Innovative vaccine trial for lung adenocarcinoma<br />

approved by FDA.<br />

• A role for perforin in lymphocyte homeostasis<br />

revealed: cytotoxicity by<br />

perforin is necessary to remove antigen<br />

presenting <strong>cell</strong>s and turn off T <strong>cell</strong><br />

activation.<br />

Richard L. Riley, Ph.D.<br />

Professor of Micro<strong>biology</strong><br />

and Immunology<br />

DESCRIPTION OF RESEARCH<br />

Altered B Cell Development in<br />

Senescence<br />

Senescent mice show diminished B lymphopoiesis<br />

when compared to young<br />

mice and typically exhibit decreased<br />

numbers of pre-B <strong>cell</strong>s in the bone marrow.<br />

Dr. Riley’s laboratory has shown that<br />

the molecules, λ5 and VrpeB, which<br />

comprise the surrogate light chain component<br />

of the pre-B <strong>cell</strong> receptor, are reduced<br />

in pro-B/early pre-B <strong>cell</strong>s both ex<br />

vivo and when derived in vitro from the<br />

bone marrow of 18-27-month-old<br />

BALB/c mice after stimulation with IL-<br />

7. Both λ5 and VpreB expression were<br />

decreased at the mRNA level as indicated<br />

by semi-quantitative RT-PCR; this suggests<br />

that the reduced surrogate light<br />

chains seen in senescent B <strong>cell</strong> precursors<br />

result from dysfunctional transcriptional<br />

regulation. The transcription of<br />

surrogate light chains is principally regulated<br />

by E2A (E47) and Early B <strong>cell</strong> Factor<br />

(EBF) gene products. EBF mRNA<br />

levels were estimated to be only slightly<br />

reduced in cultured senescent pro-B/<br />

early pre-B <strong>cell</strong>s (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!